Enerji Metabolizması, Obezite ve Hormonlar

Yıl 2020, Cilt: 4 Sayı: 1, 30 - 60, 25.06.2020

Derya Selda Sınar Nasuh Evrim Acar İrfan Yıldırım

https://doi.org/10.32706/tusbid.719671

Öz

Obezite; insan sağlığını bozacak ölçüde vücut yağ dokularında aşırı miktarda yağ birikmesi olan kronik bir sağlık sorunudur. Obezitenin gelişiminde rol oynayan genetik, kişisel ve çevresel etkenler enerji dengesinin bozulmasına neden olur. Bu etkenlerden biri olan hormonların enerji metabolizması üzerindeki etkileri güncel araştırma konularındandır ve kilo artışı ile ilişkili olan hormonların iyi bilinmesi önem arz etmektedir. Son yıllarda hormonların kilo kontrolünde ve enerji metabolizmasındaki rolü hakkında bilgiler gün ışığına çıkmaktadır. Geleneksel derleme yöntemi ile oluşturulan bu çalışmada; Pub Med, Google Scholar ve Web of Science veri tabanlarındaki obezite, enerji metabolizması ve hormon anahtar kelimelerikullanılarak, enerji metabolizması ve obezitede etken olan biyokimyasal parametreler (hormonlar) literatürde yapılan çalışmalara bağlı olarak incelenip değerlendirilmiştir. İncelenen çalışmalar neticesinde, hormonların obezite oluşumunda bir risk faktörü oluşturabileceği ve bunların metabolik etkilerinin önemini belirtmek için uzun vadeli deneysel çalışmalara ihtiyaç duyulduğu görülmektedir.

Anahtar Kelimeler

Obezite, Hormonlar, Enerji metabolizması

Energy Metabolism, Obesity and Hormones

Öz

Obesity is a chronic health problem with excessive accumulation of fat in body fat tissues to the extent that it impairs human health. Genetic, personal and environmental factors that play a role in the development of obesity cause energy balance to be disrupted. The effects of one of these factors, hormones, on energy metabolism are among current research topics and it is important to know the hormones associated with weight gain. Information concerning the role of hormones in weight control and energy metabolism has been coming to light in recent years. In this study, created with the traditional compilation method, biochemical parameters (hormones), which are the factors affecting energy metabolism and obesity, have been examined and evaluated by using the keywords of obesity, energy metabolism and hormone in Pub Med, Google Scholar and Web of Science databases. As a result of the studies examined, it can be seen that hormones may be a risk factor in the formation of obesity and long-term experimental studies are needed to indicate the importance of their metabolic effects

Anahtar Kelimeler

Obesity, Hormones, Energy metabolism

Kaynakça

• Abaci, A., Catli, G., Anik, A., Kume, T., ve Bober, E., (2013). Therelation of serum nesfatin-1 level with metabolicand clinical parameters in obese and healthy children. Pediatr Diabetes, 14(3), 189-95.
• Abiles, V., Rodriguez-Ruiz, S., Abiles, J., Mellado, C., Garcia, A., Perez de la Cruz, A., Fernandez-Santaella, M.C., (2010). Psychological characteristics of morbidly obese candidates for bariatric surgery. Obes Surg 20:161–167
• Ahren, B., Pacini, G., (1999). Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice. The American Journal of Physiology, 277(6 Pt. 1), E996–E1004.
• Al Adsani, H., Hoffer, L. J., ve Silva, J. E., (1997). Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. The Journal of Clinical Endocrinology and Metabolism, 82(4), 1118–1125.
• Alkaç, Ç., Akbaş, F., Alkaç, B., ve Atmaca, H. U., (2014). Obezitede tiroid fonksiyonları. JAREM, 2, 74-6.
• Altunkaynak, B., Özbek, E., (2007). Obezite: Nedenleri ve tedavi seçenekleri. Dicle Tıp Dergisi, 34(2), 144-149.
• Altunoğlu, E., Ülgen, E., Müderrisoğlu, C., Erdenen, F., Boz, M., (2011). Obezite ve Tiroid Fonksiyonları. İstanbul Tıp Dergisi, 12(2):69-71.
• Altunoğlu, E., Ülgen, E., Müderrisoğlu, C., ve Erdenen, F., (2009). Obezite ve tiroid fonksiyonları. İstanbul Tıp Dergisi, 24-25.
• Amatruda, J. M., Danahy, S. A., ve Chang, C. L., (1983). The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes. The Biochemical Journal, 212(1), 135–141.
• Araujo, A.B., Esche, G. R., Kupelian, V., O’Donnell, A.B., Travison, T. G., Williams, R.E., Clark, R.V., McKinlay, J. B., (2007). Prevalence of symptomatic androgen deficiency in men. The Journal of Clinical Endocrinology & Metabolism, (92), 4241–4247.
• Arıkan, Ş., (2013). Üniversite Öğrencilerinin Vücut Ağırlığı, Vücut Kitle İndeksi, Plazma Büyüme Hormonu, Grelin, Leptin Düzeyleri Ve Dayanıklılık Antremanı Arasındaki İlişkiler. Selçuk Üniversitesi Sağlık Bilimleri Enstitüsü Doktora Tezi.
• Arıkan, Ş., (2017). İnsanlarda Açlık ve Tokluk Hissinin Oluşması. Selçuk Üniversitesi Beden Eğitimi ve Spor Yüksekokulu.
• Arora, S., (2006). Role of neuropeptides in appetite regulation and obesity. Neuropeptides, 40, 375-401.
• Aslan K., Serdar Z., H., Tokullugil, H.A., (2004). Multifonksiyonel hormon: Leptin. Uludag Üniv. Tıp Fak. Derg. 30 (2): 113-118.
• Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E., ve ark., (2011). Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. International Journal of Obesity (London), 36, 843–854.
• Aydın, S., Özkan, Y., Caylak, E., (2006). Grelin ve Biyokimyasal Fonksiyonları. Türkiye Klinikleri J Med, 26;272-283.
• Aydın, S., (2007).Discovery of GhrelinHormone: ResearchandClinical Applications. Turk J Biochem, 32(2), 76–89.
• Austin, J., ve Marks, D., (2008). Hormonal regulators of appetite. International journal of pediatric endocrinology, 2009(1), 1-9.
• Aydın, S., Kuloglu, T., Yilmaz, M., Kalayci, M., Sahin, İ., ve Cicek, D., (2013). Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running. Peptides, 50, 13-18.
• Aydın, S., (2014). Three new players in energy regulation: preptin, adropin and irisin. Peptides;56:94- 110.
• Azzout-Marniche, D., Becard, D., Guichard, C., Foretz, M., Ferre, P., ve Foufelle, F., (2000). Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. The Biochemical Journal, 350, 2389–2393.
• Babaoğlu, K., Hatun , Ş., (2002). Çocukluk Çağında Obezite. Sürekli TIP Eğitimi Dergisi (STED) cilt 11,1 -8
• Barazzoni, R., Bosutti, A., Stebel, M., Cattin, M. R., Roder, E., Visintin, L., ve ark., (2005). Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism, 288(1), E228–E235.
• Başkal, N., (2002). Obezitenin Önemi ve Tedavi İlkeleri, Aknem Dergisi,; 16(3): 330-332.
• Bauer, P.V., Hamr, S.C., Duca, F.A., (2016). Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota. Cell Mol Life Sci; 73: 737-55.
• Behme, M. T., (1996). Leptin: Product of theobese gen. Nutr. Today, 31, 138-141.
• Ben Shlomo, S., Zvibel, I., Shnell, M., Shlomai, A., Chepurko, E., Halpern, Z., ve ark., (2011). Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. Journal of Hepatology, 54(6), 1214–1223.
• Benedetto, C., Salvagno, F., Canuto, E. M. , Gennarelli, G., (2015). Obesity and Female Malignancies. Best Pract Res Clin Obstet Gynaecol. 29(4):528-540. doi: 10.1016/j.bpobgyn.2015.01.003.
• Benson, S., Arck, P.C., Tan, S., Mann, K., Hahn, S., Janssen, O.E., Schedlowski, M., Elsenbruch, S.. (2009). Effects of obesity on neuroendocrine, cardiovascular, and immune cell responses to acute psychosocial stress in premenopausal women. Psychoneuroendocrinology 34:181–189.
• Berköz, M., ve Yalın, S., (2008). Yağ Dokusunun İmmunolojik ve İnflamatuvar Fonksiyonları, Mersin Üniv Sağlık Bilim Derg., 1(1): 1-9.
• Bessonova, L., Marshall, S.F., Ziogas, A., Largent, J., Berstein, L., Henderson, K.D., Ma, H., West, D.W., Anton- Culver, H., (2011). The association of body mass index with mortality in the California Teachers Study. Int J Cancer. 129(10):2492–2501.
• Bhaskaran, K., Douglas, I., Forbes, H. ve ark., (2014). Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384:755–765
• Bilge, U., Gültekin, G., Bilgin, M., ve Ünlüoğlu, İ., (2016). Bir Aile Hekimliği polikliniğine başvuran kırk yaş altı populasyonda obezite ve insülin direnci oranları. Türkiye Aile Hekimliği Dergisi, 20(2), 50-53.
• Bilgin, H. M., (2006). Ghrelin; gündemdeki hormon. Dicle Tıp Dergisi, 33, 4.
• Binay, Ç., Paketçi, C., Güzel, S., ve Samancı, N., (2017). Serum irisin and oxytocin levels as predictors of metabolic parameters in obese children. Journal of clinical research in pediatric endocrinology, 9(2), 124.
• Blanchette, S,. Blouin, K., Richard, C., Dupont, P., Luu-The, V., Tchernof, A., (2005). Expression and activity of 20-hydroxysteroid dehydrogenase (AKR 1C1) in abdominal subcutaneous and omental adipose tissue in women. J Clin Endocrinol Metab; 90: 264–270
• Blanchette, S., Marceau, P., Biron, S., Brochu, G., Tchernof, A., (2006). Circulating Progesterone and Obesity in Men. Horm Metab Res; 38: 330–335
• Blouin, K., Blanchette, S., Richard, C., Dupont, P., Luu-The, V., Tchernof, A. (2005). Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women. Am J Physiol Endocrinol Metab; 288 : E398–E404
• Bolt, H.M., ve Göbel, P., (1972). Formation of estrogens from androgens by human subcutaneous adipose tissue in vitro. Horm Metab Res., 4:312-3. 61.
• Bujalska, I.J., Kumar, S., Hewison, M., Stewart, P.M., (2002). A switch in thedehydrogenase to reductase activity of 11β-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab., 87:1205-10.
• Buscemi, S., Verga, S., Maneri, R., ve ark., (1997). Influences of obesity and weight loss on thyroid hormones. A 3–3.5-year follow-up study on obese subjects with surgical bilio-pancreatic by-pass. J Endocrinol Invest; 20(5):276–81.
• Carlson, M. J., Thiel, K., Yang, S., Leslie, K. K., (2012). Catch It Before It Kills: Progesterone, Obesity, and the Prevention of Endometrial Cancer. Discov Med. 14 (76): 215–222.
• Carolina, D., Valencia, M., Mericq, V., Corvalán, C., Pereira, A., (2020). Obesity and Related Metabolic Biomarkers and Its Association with Serum Levels of Estrogen in Pre-pubertal Chilean Girls. Endocrine Research, 45:2, 102-110, DOI:10.1080/07435800.2019.1681448
• Chen, C.Y., Asakawa, A., Fujimaya, M., Lee, S.D., ve Inui, A., (2009).Ghrelin gene productsandtheregulation of foodintakeand gut motility. PharmacolRev., 61:430–481.
• Chomard, P., Vernhes, G., Autissier, N., ve ark., (1985). Serum concentrations of total T4, T3, reverse T3 and free T4, T3 in moderately obese patients. Hum Nutr Clin Nutr; 39(5):371–8.
• Cinaz, P., Yeşilkaya, E., ve Kaya, A., (2009). Obez Çocuklarda Plazma Grelin, Serum IGF- Ve IGFBP-3 Düzeyleri. İstanbul Tıp Fakültesi Dergisi, 72(2): 47-31.
• Cohen, P.G., (2001). Aromatase, adiposity, aging and disease. The hypogonadal-metabolic atherogenic-disease and aging connection. Med Hypotheses, 56:702-8.
• Cohen, S., Janicki-Deverts, D., (2012). Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 2009. J Appl Soc Psychol.;42:1320–1334.
• Combs, T.P., Berg, A.H., Rajala, M.W., Klebanov, S., Iyengar, P., Jimenez-Chillaron, J.C.,Patti,.M.E., Klein, S.L., Weinstein, R.S., Scherer, P.E., (2003). Sexual differentiation, preg-nancy, calorie restriction, and aging affect the adipo-cyte-specific secretory protein adiponectin. Diabetes, 52(2):268-76.
• Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., ve ark., (1996). Serum Immunreactiveleptin Concentrations in Normal-Weight and Obese humans, N Engl J Med; 334:292-5.
• Cooke, P.S., Naaz, A., (2004). Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood) 229(11): 1127-1135.
• Coyoy, A., Guerra-Araiza, C., Camacho-Arroyo, I., (2016). Metabolism Regulation by Estrogens and Their Receptors in the Central Nervous System Before and After Menopause. Horm Metab Res. DOI http://dx.doi.org/10.1055/s-0042-110320
• Crespo, C.J., Smit, E., Toriano, R.P., ve ark., (2001). Television Watching, Enerjy İntake, And Obezity İn US Children: Results From The Third National Health And Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 155 (3):360-5.
• Çam, A., ve Erdoğan, M.F., (2003). Melatonin. Ankara Üniversitesi Tıp Fakültesi Mecmuası 56(2):103-112.
• Dagogo, J.S., Fanelli, C., Paramore, D., Brothers, J., Landt, M., (1996). Plasma Leptin and Insulin Relationships in Obese and Nonobese Humans. Diabetes, 45:695-698.
• De Ronde, W., van der Schouw, Y.T., Pols, H.A., Gooren, L.J., Muller, M., Grobbee, D.E., de Jong, F. H., (2006). Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clinacal Chemistry 52, 1777.
• De Rosa, G., Della Casa, S., Corsello, S.M., ve ark., (1983). Thyroid function in altered nutritional state. Exp Clin Endocrinol;82(2):173–7.
• De Spiegelace, M., Draimax, M., Henhert, P., (1998).The influence of socioeconomic status on the incidence and evaluation of obezityduring early adolesance. İnt J Obez Relat Metab Disord:22;268-74
• Deniz, G. ve Saygı, Ş., (2002). Leptin, Neuropeptide Y and Obesity. T Klin. Tıp Bilimleri, 22, 217-220.
• Deniz, R., Gurates, B., Aydin, S., Celik, H., Sahin, I., Baykus, Y., ve ark., (2012). Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine.;42(3):694-9.
• Dhindsa, S. (2010). Testosterone Concentrations in Diabetic and Nondiabetic Obese Men. Diabetes Care. 33, 1186-92.
• Donders, S.H., Pieters, G.F., Heevel, J.G., ve ark., (1985). Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity. J Clin Endocrinol Metab;61(1):56–9.
• Douyon, L., ve Schteingart D.E., (2002). Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am., 31:173-89.
• Dowsett, M., Folkerd, E., (2015). Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Res Treat 149:1–4
• Doyle, A.C., le Grange, D., Goldschmidt, A., Wilfley, D.E., (2007). Psychosocial and physical impairment in overweight adolescents at high risk for eating disorders. Obesity Silver Spring 15: 145- 154.
• Doyle, S.L., Donohue, C.L., Finn, S.P., ve ark., (2012). IGF-I and its receptor in esophageal cancer: association with adenocarcinoma and visceral adiposity. The American Journal of Gastroenterology, 107:196–204.
• Drewa, T., Olszewska-Slonına, D., Chlosta, P., (2011). Testosterone replacement therapy in obese males, Acta Poloniae Pharmaceutica Drug Research, Vol. 68 No. 5 pp. 623-627.
• Dubern, B. ve Clement, K. (2012). Leptin and leptin receptor-related monogenic obesity. Biochimie, 94(10), 2111-2115.
• Dursun, N., (2005). Leptinin kardiyovasküler etkileri. Erciyes Tıp Derg. 27(4): 167-176.
• Ekinci, F., Uzuner, A. ve Tosun, N., (2013). Çocuklarda Tiroid Hormon Düzeylerinin Obezite ile İlişkisi. Türk Aile Hek. Derg., 17(3), 101-105.
• Emokpae, M. A., ve Obazelu, P. A., (2017). The Association of Triiodothyronine-to-Thyroxine Ratio with Body Mass Index in Obese Nigerian Children and Adolescents. Medical Sciences, 5(4), 36.
• Erarslan, E., Yüksel, İ., ve Haznedaroğlu, S., (2012). Kolorektal Karsinogenez ve Metabolik Sendrom İlişkisi, Cumhuriyet Tıp Dergisi, 34: 380-385
• Erdemir, F., (2013). The evaluation of the relationship between obesity and male ınfertility. Journal of Clinical and Analytical Medicine, 4(1): 76-82.
• Ergün, A., (1999). Leptin (ob protein). T Klin Tıp Bil. 19: 130-1369.
• Espelund, U., Bruun, J.M., Richelsen, B., Flyvbjerg, A., Frystyk, J. (2005). Pro- and mature IGF-II during diet-induced weight loss in obese subjects. European Journal of Endocrinology. 153(6):861–869.
• Escoté, X., Gómez-Zorita, S., López-Yoldi, M., Milton-Laskibar, I., Fernández-Quintela, A., Martínez, J.A., (2017). Role of omentin, vaspin, cardiotrophin-1, TWEAK and NOV/CCN3 in obesity and diabetes development. Int J Mol Sci.18(8).
• Fakı, Y., (2009). Obez Tip 2 Diabetes Mellutuslu Hastalarda, Serum Aktive Ghrelin Hormonunun Glisemik Kontrol Üzerine Etkisi. Uzmanlık Tezi, Okmeydanı Eğitim ve Araştırma Hastanesi 1. Dahiliye Kliniği : 75
• Fantuzzy, G. ve Faggioni, R., (2000). Leptin in theregulation of immunity, inflammation, andhematopoiesis. J LeukocBiol, 68, 437-446.
• Fardet, L., Fève, B., (2014). Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. Drugs. Oct; 74(15):1731-45.
• Farr, O. M., Gavrieli, A., ve Mantzoros, C. S., (2015). Leptinapplications in 2015. Currentopinion in endocrinology, diabetes, andobesity, 22(5), 353.
• Favero, G., Franceschetti, L., Buffoli, B., Moghadasian, M.H., Reiter, R.J., Rodella, L.F., Rezzani, R., (2017). Melatonin: Protection against age–related cardiac pathology. Ageing Research Reviews., 35:336–349.
• Fowke, J.H., Matthews, C.E., Yu, H., ve ark., (2010). Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Endocrine-Related Cancer, 17(1):51–60.
• Frühbeck, G., Jebb, S.A., Prentice, A.M., (1998). Leptin: physiology and pathophysiology. Clin Physiol, 18, 399-419.
• Gallardo, N., Bonzon-Kulichenko, E., Fernandez-Agullo, T., Molto, E., Gomez-Alonso, S., Blanco, P., ve ark., (2007). Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology, 148(12), 5604–5610.
• Gar,C., Rottenkolber, M., Haenelt, M. ve ark., (2020). Altered metabolic and hormonal responses to moderate exercise in overweight/obesity, Metabolism, https://doi.org/10.1016/j.metabol.2020.154219
• Gathercole, L. L., Bujalska, I. J., Stewart, P. M., & Tomlinson, J. W., (2007). Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue. The Journal of Clinical Endocrinology and Metabolism, 92(11), 4332–4339.
• Gathercole, L. L., Morgan, S. A., Bujalska, I. J., Hauton, D., Stewart, P. M., ve Tomlinson, J. W., (2011). Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue. PLoS One, 6(10), e26223.
• George, S.A., Khan, S., Briggs, H., Abelson, J.L., (2010). CRH-stimulated cortisol release and food intake in healthy, non-obese adults. Psychoneuroendocrinology, 35:607–612.
• Giovannucci, E., Rimm, E.B., Liu, Y., Leitzmann, M., Wu, K., Stampfer, M.J., ve ark., (2003). Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst., 95: 1240-1244.
• Görar, S., Çulha, C., ve Demir, S., ve ark., (2006). Obezite ve tiroid fonksiyonları. Endokrinolojide Diyalog, 3:26-30.
• Guyton, A.C., Hall, J.E., (1997). Human Physiology And Mechanisms Of Disease, 16th ed. WB Saunders,: 486,584.
• Güler, D., (2018). Egzersiz ve Besinler. Bedray Basın Yayıncılık, 4-5.
• Gültekin, G., Ünlüoğlu, İ., Bilgin, M. ve Bilge, U., (2016). Bir Aile Hekimliği polikliniğine başvuran kırk yaş altı populasyonda obezite ve insülin direnci oranları. Türkiye Aile Hekimliği Dergisi, 20(2), 50-53.
• Gültürk, S., Erdal, S., Özdemir, E., Candan, F., Özdemir, Ü., Erselcan, T., (2003). Tip 2 Diabetes Mellitus'lu Hastalarda Serum Leptin Seviyeleri İle Bazal Metabolizma Hızı, İnsülin ve Vücut Kitle İndeksi Arasındaki İlişki, C. Ü. Tıp Fakültesi Dergisi, 25 (3):122.
• Hagemann, D., Meier, J.J., Gallwitz, B, Schmidt, W.E., (2003). Appetite regulation by ghrelin – a novel neuro-endocrine gastric peptide hormone in the gut-brain-axis. Z. Gastroenterol, 41(9), 929-936.
• Hassink, S.G.,Sheslow, D.V., De Lancey, E., Opentanova, I., Considine, R. V. ve Caro, J. F., (1996). Serum leptinconcentrations in childrenwithobesity: relationshiptogenderanddevelopment. Pediatrics, 98, 201-203.
• Heine, P.A., Taylor, J.A., Iwamoto, G.A., Lubahn, D.B., Cooke, P.S., (2000). Increased adipose tissue in male and female estrogen receptor α knockout mice. Proc Natl Acad Sci U S A.;97(23):12729-34.
• Hekimoglu, A., (1999). Leptin ve fizyopatolojik olaylardaki rolü. Dicle Tıp Derg. 33 (4): 259-267, 2006.
• Hekimoğlu. A., (2006). Leptin ve Fizyopatolojik Olaylardaki Rolü, Dicle Tıp Dergisi, 33(4): 259-267.
• Hong, S.C., Yoo, S.W., Cho,. GJ., Kim, T., Hur, J.Y., Park, Y.K., Lee, K.W., Kim, S.H., (2007). Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause;14(5):835-40.
• Hotta, K., Funahashi, T., Bodkin, N.L., Ortmeyer, H.K., Arita, Y., Hansen, B.C., Matsuzawa, Y., (2001). Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensi-tivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes, 50(5):1126-33.
• Huda, M.S., Wilding, J.P., Pinkney, J.H., (2006). Gut peptides and the regulation of appetite. Obes Rev; 7: 163-82
• http://tekharf.org/images/2005/08.pdf, Erişim Tarihi: 03.12.2017
• https://www.betterhealth.vic.gov.au/health/HealthyLiving/obesity hormones?viewAsPdf=true, Erişim Tarihi: 02.12.2018.
• İlhan, T., Erdost, H., (2009). Ghrelin. Uludag Univ. J. Fac. Vet. Med., 28(1), 67-74.
• İnci, A., Aypak, S. Ü. (2016). İrisin ve Metabolik Etkileri. Turkiye Klinikleri Journal of Endocrinology, 11(1), 15-21.
• İpekçi, S. H. ve Kebapcılar, L., (2013). Obezite ve Gastrointestinal Sistem İlişkisi. Turkiye Klinikleri Journal of Endocrinology Special Topics, 6(1), 65-71.
• İyidoğan, Y., (2007). Grelin Yapısı ve Organizmadaki Fonksiyonları. İstanbul Tıp Fakültesi Dergisi, 70;82-92.
• Jabari, M., Dahmash, A., Alotaibi, F., Aldebasi, M., Aloyouny, S., (2017). Thyroid Dysfunction in Obese Children and Adolescents. International Journal Of Current Medical And Pharmaceutical Research, 3, 1517-1520.
• Jarow, J.P., Kirkland, J., Koritnik, D.R., Cefalu, W.T., (1993). Effect of obesity and fertility status on sex steroid levels in men. Urology, 42:171-4.
• Jiang, G., Zhang, B. B., (2003). Glucagon and regulation of glucose metabolism. American Journal of Physiology. Endocrinology and Metabolism, 284(4), E671–E678.
• Jiménez–Aranda, A., Fernández–Vázquez, G., Campos, D., Tassi, M., Velasco–Perez, L., Tan, D.X., Reiter, R.J., Agil, A., (2013). Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. Journal of Pineal Research., 55(4):416–423.
• Kaaks, R., Lukanova, A., Kurzer, M. S., (2002). Obesity, Endogenous Hormones, and Endometrial Cancer Risk: A Synthetic Review. Review Cancer Epidemiol Biomarkers Prev. 11(12):1531-43.
• Kara, H., (2014). Diyet Yapan Obez Bireylerde Leptin, Grelin, Nesfatin 1, Obestatin Biyokimyasal Parametreleri ile Kilo Verme Arasındaki İlişki. Balıkesir Üniversitesi. Sağlık Bilimleri Enstitüsü. Tıbbi Biyokimya Anabilim Dalı Yüksek Lisans Tezi, Balıkesir.
• Karakoç, A., Törüner, F.B., Ayvaz, G., Yetkin, İ., Yıldırım, Y., Çakır, N., Arslan, M., (2004). Obez hastalarda antropometrđk ölçümlerle kortizol, dehđdroepđandrosteron-sülfat ve aterojenđk risk faktörleri arasındaki ilişki. Turkiye Klinikleri J Endocrin, 2:196-19.
• Kabiri, A., Hosseinzadeh-Attar, M.J., Haghighatdoost, F., Eshraghian, M., Esmaillzadeh, A., (2017). Impact of olive oil-rich diet on serum omentin and adiponectin levels: a randomized cross-over clinical trial among overweight women. Int J Food Sci Nutr;68(5):560-8.
• Kaufman, J.M., Vermeulen, A., (2005). The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews, Volume 26 (6), 833–876.
• Kayaalp, A., (2009). Kayaalp Rasyonel Tedavi Yönünden Tıbbi Farmakoloji (12), 2, Pelikan Yayıncılık, Ankara, 1039-1079.
• Keçetepen, L.O., Dursun, N., (2006). Egzersizin leptin düzeyleri üzerine etkisi, leptinin solunum ve kardiyovasküler parametrelerle iliskisi. Erciyes Üniv. Saglık Bil. Derg. 15(1): 1-7.
• Kelly , D. M., ve Jones ,T. H., (2015). Testosterone and obesity, Obesity Reviews 16, 581–606.
• Kelly, M.J., Qiu, J., Rønnekleiv, O.K., (2005). Estrogen Signaling in the Hypothalamus. Vitamins & Hormones; 71,123-145.
• Kendall, B., Esron, R., (2002). Exercise-induced muscle damage and the potential protective role of estrogen. Sports Med;32(2):103-23.
• Kırım, S., (2005). Obez Hastalarda Diyet, Egzersiz ve İlaç Tedavisinin Homosistein Düzeylerine Etkisi, Yan dal uzmanlık tezi, Çukurova Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı Endokrinoloji ve Metabolizma Hastalıkları Bilim Dalı, Adana: 35
• Kim, E.S., Park, J.H., Lee, M.K., ve ark., (2011). Associations between fatness, IGF and IMT among obese Korean male adolescents. Journal of Diabetes & Metabolism;35:610–618.
• Kim, B., (2008). Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid, 18(2), 141–144.
• Kim, J. H., Cho, H. T., Kim Y. J., (2014). The role of estrogen in adipose tissue metabolism: insights into glucose homeostasis regulation. Endocrine Journal, 61 (11), 1055-1067.
• Kimura, K., Tsuda, K., Baba, A., Kawabe, T., Boh-oka, S., Ibata, M., Moriwaki, C., Hano, T., Nishio, I., (2000). Involvement of nitric oxide in endotheliumdependent arterial relaxation by leptin. Biochem Biophys Res Commun. 273: 745– 749.
• Klein, S., Coppack, S.W., Mohamed-Ali, V., ve ark., (1996). Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes; 45: 984–987.
• Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K., (1999). Ghrelin is growth-hormone-releasing acylated peptide from stomach, Nature 402, 656-660.
• Kokkoris, P., Pi Sunyer, F.X., (2003). Obesity and endocrine disease. Endocrinol Metab Clin N Am. 32 895-14.
• Kopelman, P.G., ve Stock M. J., (1998). Klinik Obezite. Blackwell Science, Tekin yayınevi, Ankara, s.120-556, 1998.
• Krotkiewski M. (2002). Thyroid hormones in the pathogenesis and treatment of obesity. Eur J Pharmacol, 440:85-98.
• Knutson, K.L., Van Cauter, E., Rathouz, P.J., DeLeire, T., Lauderdale, D.S., (2010). Trends in the prevalence of short sleepers in the USA: 1975-2006. Sleep.33(1):37–45.
• Kubilay, A., (2010). IRS 2 Gen Polimorfizmi ile Obezite Arasındaki İlişki, Yüksek Lisans Tezi, Mersin Üniversitesi Sağlık Bilimleri Enstitüsü, Mersin, 50.
• Lacasa, D., Le Liepvre, X., Ferre, P., Dugail, I., (2001). Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory elementbinding protein 1c gene expression. potential mechanism for the lipogenic effect of progesterone in adipose tissue. J Biol Chem; 276: 11512–11516
• Lanfranco, F., Motta, G., Minetto, M.A., Ghigo, E., Maccario, M., (2010). Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update. Journal of Endocrinological Investigation. 33(3):192–196.
• Lanfranco, F., Zirilli, L., Baldi, M., Pignatti, E., Corneli, G., Ghigo, E., ve ark., (2008). A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone.;43(3):628-35.
• Larsson, H., ve Ahren, B., (1996). Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women: Diabetes Care,19:1399-403.
• Levine, J.A., Lanningham-Foster, L.M., McCrady, S.K., Krizan, A.C., Olson, L.R., Kane, P.H., ve ark., (2005). Interindividual variation in posture allocation: possible role in human obesity. Science. 307(5709):584-6.
• Lewandowski, K., Horn, R., O'Callaghan, C.J., ve ark., (1999). Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies. J Clin Endocrinol Metab. 84: 300±306.
• Lewitt, M. S., Dent, M.S., Hall, K., (2014). The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus. J Clin Med. Dec. 3(4): 1561–1574.
• Lizcano, F., Guzmán, G., (2014). Estrogen Deficiency and the Origin of Obesity during Menopause. BioMed Research International, DOI: http://dx.doi.org/10.1155/2014/757461
• Liu, Y., Ding, J., Bush, T. L., Longenecker, J. C., Nieto, F. J., Golden, S. H., ve ark., (2001). Relative androgen excess and increased cardiovascular risk after menopause: A hypothesized relation. American Journal of Epidemiology, 154(6), 489–494.
• Longcope, C., Feldman, H.A., McKinlay, J.B., Araujo, A.B., (2000). Diet and Sex Hormone-Binding Globulin. J. Clin. Endocrinol Metab. 85:1, 293-296.
• Lönn, L., Kvist, H., Ernest, I., Sjöström, L., (1994). Changes in body composition and adipose tissue distribution after treatment of women with Cushing’s syndrome. Metabolism. 43:1517-22.
• Lukanova, A., Lundin, E., Zeleniuch-Jacquotte, A., ve ark., (2004). Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. European Journal of Endocrinology, 150(2):161–171.
• Lundholm, L., Zang, H., Hirschberg, A. L., Gustafsson, J. A., Arner, P., ve Dahlman- Wright, K., (2008). Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertility and Sterility, 90(1), 44–48.
• Maffei, L., Murata, Y., Rochira, V., Tubert, G., Aranda, C., Vasquez, M., ve ark. (2004). Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate and estradiol treatment. J Clin Endocrinol Metab.; 89(1):61-70
• Marras, V., Casini, M. R., Pilia, S., Carta, D., Civolani, P., Porcu, M., Uccheddu, A. P. ve Loche, S., (2010). Thyroid function in obese children and adolescents. Hormone research in paediatrics, 73(3), 193-197.
• Martin T.L., Alquier T., Asakura K., Furukawa N., Preitner F., Kahn B.B. (2006). Diet-induced obesity alters AMP kinase activity in hypotalamus and skeletal muscle. J. Biol. Chem., 281, 18933-18941.
• Martins, C. M., Faleiro,L. L., ve Fonseca, A., (2012). Relationship between leptin and body mass and metabolic syndrome in an adult population. RevistaPortuguesa de Cardiologia (English Edition), 31(11), 711-719.
• Mattsson, C., Olsson, T. (2007). Estrogens and glucocorticoid hormones in adipose tissue metabolism. Curr Med Chem. 14 (27): 2918-2924.
• McConway, M.G., Johnson, D., Kelly, A., Griffin, D., Smith, J., Wallace, A.M., (2000). Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans. Ann Clin Biochem;37:717-23.
• McInnes, K. J., Brown, K. A., Hunger, N. I., ve Simpson, E. R., (2012). Regulation of LKB1 expression by sex hormones in adipocytes. International Journal of Obesity, 36(7), 982–985.
• McTiernan, A., Stanfors, J.L., Daling, J.R., (1998). Prevalence and correlates of recreational physical activity in women aged 50-64 years. Menopause. 5(2):95-101.
• Mehmetoğlu, İ., (2006). Bilimsel Gerçekler Işığında Gıdalar ve Sağlıklı Beslenme. Yelken Basım Yayım Dağıtım. Konya, 182-183.
• Mendes, A. M., Madon, R. J., ve Flint, D. J., (1985). Effects of cortisol and progesterone on insulin binding and lipogenesis in adipocytes from normal and diabetic rats. The Journal of Endocrinology, 106(2), 225–231.
• Meng, J.F., Shi, T.C., Song, S., Zhang, Z.W., Fang, Y.L., (2017). Melatonin in grapes and grape–related foodstuffs: A review. Food Chemistry. 231: 185–191.
• Merlino, D.J., Blomain, E.S., Aing, A.S., (2014). Gutbrain endocrine axes in weight regulation and obesity pharmacotherapy. J Clin Med. 3:763-94.
• Merali, Z., Cayer, C., Kent, P., Anisman, H., (2008). Nesfatin-1 increases anxiety-and fear-related behaviors in the rat. Psychopharmacology (Berl). 201(1):115-23.
• Mirzaei, K., Hossein-nezhad, A., Keshavarz, S.A., Koohdani, F., Eshraghian, M.R., Saboor-Yaraghi, A.A., ve ark., (2015). Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects. Diabetes Metab Syndr. 9(4): 292-8
• Moreno-Navarrete, J.M., Catalan, V., Ortega, F., Gomez-Ambrosi, J., Ricart, W., Fruhbeck, G., Fernandez-Real , J.M., (2010). Circulating omentin concentration increases after weight loss. Nutr Metab. 7.
• Morrison, C. D., Morton, G. J., Niswender, K. D., Gelling, R. W., ve Schwartz, M. W., (2005). Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. American Journal of Physiology. Endocrinology and Metabolism, 289(6), E1051–E1057.
• Munzberg, H., ve Myers, M. G., Jr., (2005). Molecular and anatomical determinants of central leptin resistance. Nature Neuroscience, 8(5), 566–570.
• Musatov, S., Chen, W., Pfaff, D.W., Mobbs, C.V., Yang ,X.J., Clegg, D.J., ve ark., (2007). Silencing of estrogen receptor α in the ventromedial nucleus of Estrogênio e controle da massa corporal hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA.104(7):2501-6.
• Myers, M. G., (2015). Leptin keeps working, even in obesity. Cell metabolism, 21(6), 791-792.
• Myers, M. G., Leibel, R. L., Seeley, R. J., ve Schwartz, M. W., (2010). Obesity and leptin resistance: distinguishing cause from effect. Trends in Endocrinology&Metabolism, 21(11), 643-651.
• Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., ve ark., (2001). A role for ghrelin in the central regulation of feeding. Nature, 409(6817), 194–198.
• Narin, F., Atabek, M.E., Karakukcu, M., Narin, N., Kurtoglu, S., Gumus, H., Çoksevim, B., Erez, R., (2005). The association of plasma homocysteine levels with serumleptin and apolipoprotein B levels in childhood obesity. Ann Saudi Med. 25(3): 209–214.
• Onat, A., Uyarel, H., Türkmen, S., ve ark., (2004). Türk Kardiyoloji Derneği, 32:137–144.
• Onder, G., Liperoti, R., Russo, A., ve ark., (2006). Body mass index, free insulin-like growth factor I, and physical function among older adults: results from the ilSIRENTE study. American Journal of Physiology. 291(4):E829–E834.
• Ogiso, K., Asakawa, A., Amitani, H., Nakahara, T., Ushikai, M., Haruta, I., (2011). Plasma nesfatin-1 concentrationsin restricting-type anorexia nervosa. Peptides;32(1):150-3.
• Ostlund, R.E., Yang, J.W., Klein, S., Gingerich, R., (1996). Relation between plasma leptin concentration and body fat, gender,diet, age and metabolic covariates. J Clin Endocrinol Metab; 81: 3909– 13.
• Önal, Z. ve Adal, E., (2014). Çocukluk çağında obezite. Okmeydanı Tıp Dergisi Ek, (1), 39-44.
• Özata, M,. (2003). Obezite tanı ve tedavisi. Gata Basımevi, Ankara, s.1-19.
• Özçam, H., (2009). Tip 2 diyabetli obez ve obez olmayanlarda leptin ve adiponektin düzeylerinin insulin direnci ile ilişkisi. 3. İç Hastalıkları Kliniği, Haseki Eğitim ve Araştırma Hastanesi. Uzmanlık Tezi, İstanbul.
• Özen, Ş., ve Özen, G., (2011). Leptin Hormonu: Egzersiz ve Obezite İle İlişkisi. e-Journal of New World Sciences Academy, 6(2), 114-127.
• Özen, Ş. ve Tiryaki Sönmez, G., (2008). Ghrelin Hormonu ve Egzersiz. Gazi Beden Eğitimi ve Spor Bilimleri Dergisi, 3, 11-24.
• Pan, H.Y., Guo, L., Li, Q., (2010). Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pr., 88(1):29-33.
• Pan, H., Guo, J. ve Su, Z., (2014). Advances in understanding the interrelations between leptin resistance and obesity. Physiology&behavior, 130, 157-169.
• Pan, W., Hsuchou, H., Kastin, A.J., (2007). Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides. 28(11):2223-8.
• Pasquali, R., (2006). Obesity and androgens: Facts and perspectives. Fertility and Sterility, 85(5), 1319–1340.
• Price, T.O., Samson, W.K., Niehoff, M.L., Banks, W.A., (2007). Permeability of the blood-brain barrier to a nove satiety molecule nesfatin-1. Peptides. 28(12):2372-81.
• Poehlman, E. T., (2005). Transversing the menopause: Change in energy expenditure and body composition. Coronary Artery Disease, 16(8), 511.
• Ramsay, T. G., (2003). Porcine leptin inhibits lipogenesis in porcine adipocytes. Journal of Animal Science, 81(12), 3008–3017.
• Rasmussen, M.H., Juul, A., Kjems, L.L., Hilsted, J., (2006). Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects. European Journal of Endocrinology;155(4):575–581.
• Rasmussen, M.H., (2010). Obesity, growth hormone and weight loss. Molecular and Cellular Endocrinology;316(2):147–153.
• Rebuffe-Scrive, M., Krotkiewski, M., Elfverson, J., Bjorntorp, P.. (1988). Muscle and adipose tissue morphology and metabolism in Cushing’s syndrome. J Clin Endocrinol Metab. 67:1122-8.
• Reeves, G.K., Pirie, K., Beral, V., Green, J., Spencer, E., Bull ,D., (2007). Cancer incidence and mortality in relation to body mass index in the Million Women study: cohort study. BMJ. 335:1134.
• Reinehr, T., (2010). Obesity and thyroid function. Mol Cell Endocrinol, 316:165-71.
• Rodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., Frühbeck, G., (2015). Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Endocrinol Metab. 309(8):E691-714.
• Rosmond, R., Bouchard, C., Bjorntorp, P., (2002). 5HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes Res. 10(7): 585-9.
• Ruige, J.B., Dekker, J.M., Blum, W.F., Stehouwer, C.D., Nijpels, G., Mooy, J., ve ark., (1999). Leptin and Variables of Body Adiposity, Energy Balance, and Insulin Resistance in a Population-Based Study. Diabetes Care, 22:1097-104.
• Santosa, S., Jensen, M.D., (2013). Adipocyte fatty acid storage factors enhance subcutaneous fat storage in postmenopausal women. Diabetes. 62(3): 775-782).
• Sáinz, N., Barrenetxe, J., Moreno-Aliaga, M. J., ve Martínez, J. A., (2015). Leptinresistanceanddiet-inducedobesity: central and peripheral actions of leptin. Metabolism. 64(1), 35-46.
• Sancho, V., Trigo, M. V., Martin-Duce, A., Gonz, L. N., Acitores, A., Arnes, L., ve ark., (2006). Effect of GLP-1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects. International Journal of Molecular Medicine, 17(6), 1133–1137.
• Saremi, A., Asghari, M., Ghorbani, A., (2010). Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sport Sci., 28(9):993-8.
• Scarpace, P. J., ve Zhang, Y., (2009). Leptinresistance: a prediposingfactorfordiet-inducedobesity. American Journal of Physiology-Regulatory, Integrativeand Comparative Physiology, 296(3), 493-500.
• Schwartz, M.W., Woods, S.C., Porte, D. Jr., Seeley, R.J., Baskin, D.G., (2000). Central nervous system control of food intake. Nature. 404(6778): 661-71.
• Schaffler, A., Neumeier, A., Herfarth, H., Furst, A., Scholmerich, J., Buchler, C., (2005). Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Bba-Gene Struct Expr., 1732(1-3):96-102.
• Schindler, A.E., (2009). Progestogen Deficiency and Endometrial Cancer Risk. Review Maturitas. 62(4):334-7. doi: 10.1016/j.maturitas.2008.12.018.
• Schmandt, R.E., Iglesias, D.A., Co, N.N., Lu, K.H., (2011). Understanding obesity and endometrial cancer risk: opportunities for prevention. AJOG. 205(6):518–525.
• Schmitz, K.H., Neuhouser, M.L., Agurs-Collins, T., ve ark., (2013). Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst. 105:1344–1354
• Scott, K.M., McGee, M.A., Wells, J.E., Browne, M.A., (2008). Obesity and mental disorders in the adult general population. J Psychosom Res. 64:97–105.
• Scriba, P.C., Bauer, M., Emmert, D., ve ark., (1979). Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,39-L-triiodothyronine (T3), 3,39,59-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globülin (CBG), transferrin, alpha 2-haptoglobin and complement C’3 in serum. Acta Endocrinol (Copenh). 91(4):629–43.
• Seidell, J.C., Deurenberg, P., Hatvast, J.G., (1987). Obesity and fat distribution, in relatin to health. Current insights and recommendations. World Rev Nutr Diet, 50:57–91.
• Seidell, J.C., Kopelman, P.G., Stock, J.M., (2000). Yağ Topografisi, In: Klinik Obezite, Tekin Ciltevi,; 158-176.
• Semerci, C. N. (2004). Obezite ve genetik. Gülhane Tıp Dergisi, 46(4), 353-359.
• Seufert, J., Kıeffer, T.J., Leech, C.A., Holz, G.G., Moritz, W., Ricordi, C., Habener, J.F., (1999). Leptin Suppression of Insulin Secretion and Gene Expression in Human Pancreatic Islets: Implications for the Development of Adipogenic Diabetes Mellitus. J ClinEndocrinol Metab, 84:670-676.
• Silva, J.E., (1995). Thyroid hormone control of thermogenesis and energy balance. Thyroid. 5: 481–92.
• Sinha, M.K., Opentanova, I., Ohannesian, J.P., Kolaczynski, J.W., Heiman, M.L., Hale, J. (1996). Evidence of free and bound leptin in human circulation. J Clin Invest. 98:1277–82.
• Shimizu, H., Oh-I, S., Hashimoto, K., Nakata, M., Yamamoto, S., Yoshida, N., (2009). Peripheral administration of nesfatin 1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology. 150(2):662-71.
• Sönmez, B., (2008). Plazma Adniopektin Düzeyi ve Diğer İnsülin Rezistansı Parametreleri ile Mide Kanseri Arasındaki İlişki, Uzmanlık Tezi, Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi 1. Dahiliye Kliniği, İstanbul : 81.
• Spranger, J., Kroke, A., Mohlig, M., Boeing, H., (2003). Adi-ponectin and protection against type2 diabetes mellitus. Lancet. 361(9362):1060.
• Stengel, A., Mori, M., Taché, Y., (2013). The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors. Obes Rev.14(11):859-70.
• Stengel, A., Taché, Y., (2011). Minireview: nesfatin-1—an emerging new player in the brain-gut, endocrine, and metabolic axis. Endocrinology.152(11):4033-8.
• Stengel, A., Goebel, M., Wang, L., Rivier, J., Kobelt, P., Mönnikes, H., (2009). Central nesfatin-1 reduces darkphase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology;150(11):4911-9.
• Stewart, P.M., Larsen, P.R., Kronenberg, H.M., Melmed, S., Polonsky, K.S., Foster, D.W., Wilson, J.D., (2003). The adrenal cortex. Williams textbook of endocrinology. 10th ed, Philadelphia, Saunders, 491-539.
• Stewart, P.M., (2003). Tissue-specific Cushing’s syndrome, 11β-hydroxysteroid dehydrogenase and the redefinition of corticosteroid hormone action. Eur J Endocrinol, 149:163-8.
• Støving, R.K., Chen, J.W., Glintborg, D., ve ark., (2007). Bioactive Insulin-like Growth Factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism. 92(6):2323–2329.
• Strata, A., Ugolotti, G., Contini, C., Magnati, G., Pugnoli, C., Tirelli, F, ve ark., (1978). Thyroid and obesity: survey of some function tests in a large obese population. Int J Obes, 2:333–40.
• Stengel, A., (2015). Nesfatin-1-more than a food intake regulatorypeptide. Peptides, 72: 175-83.
• Strauss, J., Barbieri, R., (2004). Yen and Jaffe’s Reproductive Endocrinology. 5th edition Saunders.
• Şafak, S., (2013). Obezitenin Biyokimyasal Açıdan Değerlendirilmesi. Erciyes Üniversitesi. Eczacılık Fakültesi. Bitirme Tezi, Kayseri.
• Şahin, A., ve Yalnız, M., (2018). Obezite ve Gastrointestinal Sistem İlişkisi. Fırat Tıp Dergisi, 23, 22-29.
• Tan, B.K., Hallschmid, M., Kern, W., Lehnert, H., Randeva, H.S., (2011). Decreased cerebrospinal fluid/plasmaratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implicationsfor obesity treatment. J Clin Endocrinol Metab;96(4):E669-73.
• Tea, N.T., Castanier, M., Roger, M., (1975). Simultaneous radioimmunoassay of plasma progesterone and 17-hydroxyprogesterone normal values in children, in men and in women throughout the menstrual cycle and in early pregnancy. J Steroid Biochem. 6: 1509–1516
• Tomlinson, J. J., Boudreau, A., Wu, D. M., Salem, H. A., Carrigan, A., Gagnon, A., ve ark., (2010). Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcription factors. Molecular Endocrinology, 24(1), 104–113.
• Topal, T., Öter, Ş., Korkmaz, A., (2009). Melatonin ve Kanserle İlişkisi. Genel Tıp Dergisi, 19(3):137-14
• Tschop, M., Smiley, D.L., ve Heiman, M.L., (2000). Ghrelin induces adiposity in rodents, Nature. 407, 6806, 908-913.
• Tunçbilek, E., (2005). Obesite genetik bir hastalık mıdır? Çocuk Sağlığı ve Hastalıkları Dergisi, 48, 101-108.
• Turnbridge, W.M.G., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., ve ark., (1977). The spectrum of thyroid disease in a community. The Wickham surve Clin Endocrinol. 7: 481–5.
• Van Der Valk, E. S., Savas, M., Van Rossum, E.F. C., (2018). Stress and Obesity: Are There More Susceptible Individuals? Curr Obes Rep. 7(2): 193–203.
• Vendrell, J., El Bekay, R., Peral, B., Garcia-Fuentes, E., Megia, A., Macias-Gonzalez, M., ve ark., (2011). Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance. Endocrinology, 152(11), 4072–4079.
• Vermeulen, A., (1976). Plasma levels and secretion rate of steroids with anabolic activity in man. Environ Qual Saf 5: 171–180
• Vikan, T., Schirmer, H., Njølstad, I., Svartberg, J., (2010). Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur. J. Endocrinol. 162 (4), 747-754.
• Vincent, R.P., Ashrafian, H., le Roux, C.W., (2008). Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. Nat Clin Pract Gastroenterol Hepatol; 5: 268-77
• Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L.J., Kaufman, J.M., Legros, J-J., Lunenfeld, B., Morales, A., Morley, J. E., Schulman, C., Thompson, I. M., Weidner, W., Wu, F.C.W., (2008). Investigation, treatment and monitoring of late-onset hypogonadism in males. European Journal of Endocrinology. 159 507–514
• Wang, Y., Jones, V. B., Urs, S., Kim, S., Soltani-Bejnood, M., Quigley, N., ve ark., (2004). The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. The Journal of Nutrition, 134(5), 1032–1038.
• Weltman, A., Weltman, J.Y., Hartman, M.L., Abbott, R. D., Rogol, A.D., (1994). Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab;78(3):543–8.
• West, J.B., (1991). Best And Taylor’s Physiological Basis Of Medical practice 12th ed. Williams and Wilkins, 741,774.
• Wiper-Bergeron, N., Wu, D., Pope, L., Schild-Poulter, C., Hache, R.J., (2003). Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J 22: 2135–2145
• World Health Organization - Obesity and overweight - Fact sheet N°311 – Erişim Tarihi:15.05.2020 [http:// www.who.int/mediacentre/factsheets/fs311/en
• Wu, F.C., Swanston, I.A., Baird, D.T. ,(1982). Raised plasma oestrogens in infertile men with elevated levels of FSH. Clin Endocrinol (Oxf), 16:39-47.
• Xia, S.F., Duan, X.M., Hao, L.Y., Li, L.T., Cheng, X.R., Xie, Z.X., Qiao, Y., Li, L.R., Tang, X., Shi, Y.H., Le, G.W., (2015). Role of thyroid hormone homeostasis in obesity prone. Metabolism Clinical and Experimental, 64, 566-79.
• Yang, R.Z., Lee, M.J., Hu, H., Pray, J., Wu, H.B., Hansen, B.C., Shuldiner, A.R., Fried, S.K., McLenithan, J.C., Gong, D.W., (2006). Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol-Endoc M, 290(6):E1253-E61.
• Yavuz, C., (2015). Tokluk ve açlık hormonları, Beslenme Bilimi, Permalink 10.
• Yenigün, M., Türker, T., Ataoğlu, H.E., Temiz, L.E., Ahbab, S., (2005). From Obesity To Diabetes. Haseki Tıp Bülteni;43:1-12.
• Yiğitbaşı, T., Baskın, Y., Afacan, G., ve Harmanda, A., (2010). Obez Hastalarda Büyüme Hormonu, Leptin, Amilin, Glukagon Benzeri Peptid-1 Seviyeleri ile İnsülin DirenciArasındaki İlişki, Türk Biyokimya Dergisi 35 (3): 177–182
• Yiş, U., Öztürk, Y., ve Büyükgebiz, B., (2005). Ghrelin: Enerji Metabolizmasının Düzenlenmesinde Yeni Bir Hormon, Çocuk Sağlığı ve Hastalıkları Dergisi, 48: 196-201.
• Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F., ve Jeanrenaud, B., (1993). Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology, 133(4), 1753–1758.